CN105175370A — 一种2-氟-5-[(3-氧代-1(3h)-异苯并呋喃亚基)甲基]苯腈的合成方法
Assigned to ANHUI WANBANG MEDICAL TECHNOLOGY Co Ltd · Expires 2015-12-23 · 10y expired
What this patent protects
一种奥拉帕尼中间体2-氟-5-[(3-氧代-1(3H)-异苯并呋喃亚基)甲基]苯腈的新合成方法,以3-亚甲基异苯并呋喃-1(3H)-酮与2-氟-5-溴苯腈为反应原料,在碱性条件与金属钯类化合物的催化下,经偶联反应得到2-氟-5-[(3-氧代-1(3H)-异苯并呋喃亚基)甲基]苯腈,反应收率70%以上。与原工艺路线相比,避免了甲醇钠、甲磺酸等强碱强酸对设备腐蚀性较强类物的使用,并且缩短了反应步骤,使操作更加简便,减少了对环境的冲击力大,降低了成本。
USPTO Abstract
一种奥拉帕尼中间体2-氟-5-[(3-氧代-1(3H)-异苯并呋喃亚基)甲基]苯腈的新合成方法,以3-亚甲基异苯并呋喃-1(3H)-酮与2-氟-5-溴苯腈为反应原料,在碱性条件与金属钯类化合物的催化下,经偶联反应得到2-氟-5-[(3-氧代-1(3H)-异苯并呋喃亚基)甲基]苯腈,反应收率70%以上。与原工艺路线相比,避免了甲醇钠、甲磺酸等强碱强酸对设备腐蚀性较强类物的使用,并且缩短了反应步骤,使操作更加简便,减少了对环境的冲击力大,降低了成本。
Drugs covered by this patent
- Lynparza (olaparib) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.